In this article, the available health-economic literature in the field of comprehensive cardiac rehabilitation is reviewed. The effects of cardiac rehabilitation are well known, but cost-effectiveness studies are lacking in several important areas. The long-term effect on the number of life-years saved indicates that cardiac rehabilitation is a cost-effective use of health care resources, provided that cost-containing principles are applied in comprehensive programmes.
Task force of the Working Group on Cardiac Rehabilitation of the European Society of Cardiology: Long-term comprehensive care of cardiac patientsEur Heart J1992, 13 (suppl C):1–45.
2.
OldridgeNBGuyattGHFischerMERimmAA: Cardiac rehabilitation after myocardial infarction, combined experience of randomized clinical trialsJAMA1988, 260:945–950.
3.
ShephardRJ: Exercise in secondary and tertiary rehabilitation: Costs and benefitsJ Cardiopulmonary Rehabil1989, 9:188–194. Areview of costs and benefits of exercise training, outlining basic health-economic principles in this area.
4.
ShephardRJ: Economic benefits of secondary and tertiary cardiac rehabilitation; a critical studyAnn Acad Med1992, 21:57–62.
5.
DennisC: Cost-effectiveness in cardiac rehabilitationJ Cardiopulmonary Rehabil1991, 11:128–131. Areview of cost-effectiveness in the different elements of cardiac rehabilitation, stating that it is cost-effective.
6.
NikolaevaLFKarpovaGDRubanovichAEvadkovVAAronovDMAleshinOI: Medical, social and economic effectiveness of the USSR national staged MI patients rehabilitation programme. In Proceedings, IVth World Congress of Cardiac Rehabilitation, Brisbane. 1988:118.
7.
VasiliauskasDKrisciunasALazaraviciusA: Rehabilitation of post-infarctional patients: Socio-economic effectiveness. In Proceedings, IVth World Congress of Cardiac Rehabilitation, Brisbane, 1988:144.
8.
PicardMHDennisCSchwartzRGAhnDKKraernerHCBergerWE: Cost-benefit analysis of early return to work after uncomplicated acute myocardial infarctionAm J Cardiol1989, 63:1308–1314. Acontrolled study showing that identification of a low-risk post-myocardial infarction population by early treadmill testing combined with vocational advice could shorten the interval before return to work from 75 to 51 days.
9.
Levin LÅPerk JHedbäckB: Cardiac rehabilitation, a cost analysisJ Intern Med1991, 230:427–434. A5-year follow-up study of all costs of comprehensive rehabilitation compared with standard care, showing a per capita reduction of approximately US$ 10 000 in rehabilitation, mainly because of a higher percentage returning to work.
10.
AdesPAHuangDWeaverSO: Cardiac rehabilitation participation prediets lower rehospitalization costsAm Heart J1992, 123:916–921. Anon-randomized comparison of entrants and non-entrants into cardiac rehabilitation, showing lower rehabilitation costs among participants.
11.
OldridgeNBFurlongWFeenyDTorranceGGuyattGCroweJ: Economic evaluation of cardiac rehabilitation soon after acute myocardial infarctionAm J Cardiol1993, 72:154–161. Awell-designed randomized study of cost-benefit and cost-utility of 8-week rehabilitation for post-Mi patients with mild-to-moderate anxiety or depression, or both. The cost-utility ratio indicated an efficient use of health-care resources in comparison with other medical interventions.
12.
FridDJPashkowP: Assessing outcomes in cardiopulmonary rehabilitation - how are we doing?J Cardiopulmonary Rehabil1994, 14:334.
13.
WilliamsA: Economics of coronary artery bypass graftingBMJ1985, 291:326–329.
14.
VermeerFSimoonsMLde ZwaanCvan EsGEVerheugtFWAvan der LaarseA: Cost benefit of early thrombolytic therapy with intracoronary streptokinaseBr Heart J1988, 59:527–534.
15.
SimoonsMLVosJMartensLL: Cost-utility analysis of thrombolytic therapyEur Heart J1991, 12:694–699.
16.
KrumholzHMPasternakRCWeinsteinRCFriesingerGCRidkerPMTostesonAN: Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarctionN Engl J Med1992, 327:7–13.
17.
OlssonGLevin LÅRehnquist N: Economic consequences of postinfarction prophylaxis with β blockers: Cost effectiveness of metoprololBMJ1987, 294:339–342.
18.
GoldmanLSiaBCookEFRutherfordJDWeinsteinMC: Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarctionN Engl J Med1988, 319:152–157.
19.
StasonWB: Costs and benefits of risk factor reduction for coronary heart disease: Insights from screening and treatment of serum cholesterolAm Heart J1990, 119:718–724.
20.
LaffelGLFinebergHVBraunwaldE: A cost-effectiveness model for coronary thrombolysis/reperfusion therapyJ Am Ckll Cardiol1987, 10:79B–90B.
21.
DittuRSRoberstSDAdolphJKnoebelSB: Cost-effective management of patients following myocardial infarction: The impact of ischemia on alternative approachesPACE1988, 11:2086–2092.
22.
GoldmanL: Cost-effectiveness perspectives in coronary heart diseaseAm Heart J1990, 119:733–740.
23.
LaunbjergJBerningJFruergaardPBorch-JohnsenKEliasenPEikenPA: Early discharge after myocardial infarction. Cost-effectiveres of early risk evaluation with echocardiography [in Danish], Ugeskr Laeger1992, 154:1348–1350.
24.
DoubiletPWeinsteinMCMcNeilBJ: Use and misuse of the term ‘cost effective’ in medicineN Eng J Med1986, 314:253–256.
25.
OldridgeNBRogowskiBL: Self-efficacy and in-patient cardiac rehabilitationAm J Cardiol1990, 66:362–365.
26.
KüblerWNiebauerJKreuzerJ: Cost/use relation: Valuation of stationary and ambulant rehabilitation [in German]Z Kardiol1994, 83 (suppl 6):151–158. Aninteresting report comparing costs of outpatient rehabilitation with those of inpatient programmes in specialized cardiac rehabilitation centres.
GouldKLOrnishDKirkeeideRBrownSStuartYBuchiM: Improved stenosis geometry by quantitative coronary arteriography after vigorous risk modificationAm J Cardiol1992, 69:845–853.
29.
WittelsEHHayJWGottoAM: Medical costs of coronary artery disease in the United StatesAm J Cardiol1990, 65:432–440.
30.
CummingsSRRubinSMOsterG: The cost-effectiveness of counselling smokers to quitJAMA1988, 261:75–79.
31.
GoldmanLWeinsteinMCGoldmanPAWilliamsLW: Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of heart diseaseJAMA1991, 265:1145–1151.
32.
NielsenFE: Return to work after myocardial infarction [In Danish]. In Proceedings IIIrd Nordic Conference on Cardiac Rehabilitation, Åbo. 1993:23.
33.
McGeeHMGrahamTCroweBHorganJH: Return to work following coronary artery bypass surgery or percutaneous transluminal coronary angioplastyEur Heart J1993, 14:623–628.
34.
PerkJHedbäckBEngvallJ: Effects of cardiac rehabilitation after coronary artery bypass grafting on readmissions, return to work and physical fitnessScand J Soc Med1990, 18:45–51.
35.
HedbäckBPerkJWodlinP: Long-term reduction of cardiac mortality after myocardial infarction: 10-year results of a comprehensive rehabilitation programmeEur Heart J1993, 14:831–835.
36.
DennisC.Houston-MillerNSchwartzRG: Early return to work after uncomplicated myocardial infarction: Results of a randomized trialJAMA1988, 260:214–220.
37.
O'ConnorGTBuringJEYusufSGoldhaberSZOlmstaedEMPaffenbargerRS: An overview of randomized trials of rehabilitation with exercise after myocardial infarctionCirculation1989, 80:234–244.
38.
HugenholtzPG: On JUMBO and ‘junkie’ trials. A fumbled affair, a jungle, or the ultimate solution?Int J Cardiol1991, 33:1–4.
